Complex Ostial Disease of the Aortic Arch Vessels

Slides:



Advertisements
Similar presentations
Arterial Fibrodysplasia
Advertisements

Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
(1) Arch Debranching vs. Elephant Trunk for Hybrid Repair of the Proximal Thoracic Aorta Arch Debranching versus Elephant Trunk Procedures for Hybrid Repair.
The Cramping Leg Management of peripheral vascular disease
Spinal cord protection in surgery of descending thoracic aorta Present by R1 康庭瑞.
Andrew Bunney MD, PGY-4 University of Minnesota
M ANAGEMENT OF SYMPTOMATIC VERTEBRAL ARTERY STENOSIS Dr Sulaiman AL Shamsi Sr.consultant Vascular Surgeon Royal Hospital Oman International Vascular Coneferenec.
Results of “Type II” Hybrid Arch Repair with Zone 0 Stent Graft Deployment Jehangir Appoo, William Kent, Eric Herget, Jason Wong, Alberto Pochettino and.
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
When the blood vessels become obstructed, the tissues do not receive the necessary circulation to thrive. Over time, the area may become.
Chronic arterial occlusive diseases.  Atherosclerosis( most common cause)  Aneurysms  Thrombangitis obliterans  Inflammatory arteritis Aetiology.
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
Carotid Angiography: Information Quality and Safety Michael J. Cowley, M.D., FSCAI.
DR. Ahmed Abanamy Hospital DOCTOR Nazih Mohammed Alothman Vascular Surgeon.
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
Angioplasty and Stenting of the Great Vessels J. Bayne Selby, Jr., MD Medical University of South Carolina Institut fur Diagnostische und Interventionelle.
New guidelines for CABG
What Is Peripheral Vascular Disease? Daniel B. Walsh, M.D. Professor of Surgery, Section of Vascular Surgery Vice-Chair, Department of Sugery Dartmouth-Hitchcock.
Cardiac Case 9/15/07. Coarctation of the Aorta Congenital narrowing of the thoracic aorta; typically distal to the left subclavian artery. M:F – 2:1.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
EXTREME REVASCULARIZATION TECHNIQUES “LIMB-SAVING PROCEDURES” DISTAL BYPASSES including BYPASS at FOOT LEVEL with “in situ” saphenous vein graft.
Without Deep Hypothermia
Aneurysms of the innominate artery: surgical treatment of 27 patients. John D. Symbas, M.D., Michael E. Joseph B. Whitehead Department of Surgery, Division.
ProximAl pRotection with the MO.MA device dUring caRotid stenting proximAl pRotection with the MO.MA device dUring caRotid stenting Barry T. Katzen MD.
UPDATE IN CAROTID ARTERY STENTING & STROKE MANAGEMENT Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Endovascular treatment on tandem lesions of cranial arteries Xiao-Long Zhang, MD, PhD Department of Radiology Huashan Hospital,Fudan University Shanghai.
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Vertebral PTA: Indications and Technique Patrick L. Whitlow, MD Director, Interventional Cardiology The Cleveland Clinic Foundation Patrick L. Whitlow,
SCAI Fall Fellows Course 2012 Subclavian/Innominate Case Presentation Daniel J. McCormick DO, FACC, FSCAI Director, Cardiovascular Interventional Therapy.
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
Peripheral Vascular Disease
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.
Emerging Techniques For Management of Carotid and Brachiocephalic Occlusive Disease for Prevention of Stroke Brian Whang, Romeo Mateo, Anthony Pucillo,
Stents implantation to treat carotid lesions Lessons learned in the last 17 years Hugo Londero MD Córdoba-Argentina.
Carotid Access for TAVR: An underappreciated approach?
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
(p for noninferiority = 0.01)
UPDATE IN CAROTID ARTERY STENTING & STROKE MANAGEMENT
ISCHEMIC HEART DISEASE
Subclavian, Innominate & Vertebral Artery Treatment
Anticoagulation after peripheral Vascular Intervention
Radial Approach for CAS – tips for the novice Dr Georgi Goranov
Multi-territory Revascularization: A Sisyphean TASC?
LEFT SUBCLAVIAN ARTERY REVASCULARIZATION DURING DEBRANCHING PROCEDURE FOR ACUTE “TYPE A“ AORTIC DISSECTION USING THE LEFT INTERNAL MAMMARY ARTERY Thank.
Michael Siah, M.D. Medstar Georgetown University Hospital
Carotid Artery Stenosis
Stent Graft for the Treatment of ISR:
Antithrombotic Therapy in Peripheral Artery Disease
Coronary bifurcation wide-neck aneurysm successfully treated by provisional Y-stent-assisted coil embolization Gregory A. Sgueglia, MD, PhD Interventional.
Crossing SFA-Popliteal Artery CTO’s
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
Cardiovascular Research Technology Conference (CRT 17)
Percutaneous Reconstruction of the Aortoiliac Bifurcation
Diagnostic Medical Sonography Program
Thoracic Aortic Frontier: Review of Current Applications and Directions of Thoracic Endovascular Aortic Repair (TEVAR)  Jehangir J. Appoo, MDCM, FRCSC,
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections
Coronary Artery Surgery
VASCULAR SURGERY STATIONS
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Division of Endovascular Interventions
Vascular Surgery Michael Ricci, MD.
Thomas J Takach, George J Reul, Denton A Cooley, James J Livesay, J
Innominate artery lesions: Problems encountered and lessons learned
Presentation transcript:

Complex Ostial Disease of the Aortic Arch Vessels CRT 2016 Thoracic February 23, 2016

Christian Shults, MD   I have no relevant financial relationships

Incidence and background Thought to be an extension of aortic disease Correlation with CAD (4-7%), (66% have CAD) Correlation with PAD (11.5%) High correlation with smoking (78-100%), HTN, HLD, PAD Younger than typical PAD patients

4748 patients with symptomatic cerebrovascular disease

Subclavian/Innominate Stenosis Subclavian most affected brachiocephalic vessel by atherosclerosis L>R Hypoperfusion vs. emboli Differential BP >20mmHg ~20% symptomatic Left then right carotid Innominate lesions uncommon Usually proximal extension of Left subclavian disease or aortic arch

Symptomatic Presentation Vertebrobasilar ischemia “subclavian steal” Fisher et al N Engl J Med 1961 Dizziness, vertigo, unsteadiness/imbalance, syncope… Upper extremity claudication Fatigue, pain with exercise, “heaviness” Upper extremity ischemia Rest pain, tissue loss, ulceration Coronary steal CABG and LIMA-LAD bypass Neurologic dysfunction(ant/post circulation); UE symptoms Innominate lesions Ulcerated plaques in Innominate or CCA: TIA, neurologic dysfunction

Repair Symptomatic lesions Asymptomatic occlusion or stenosis does not typically warrant repair due to collateral network Reversal of vertebral not indication unless symptomatic Symptomatic coronary steal or in preparation for CABG.

Treatment Transthoracic approach Extrathoracic approach Endarterectomy Bypass Innominate stenosis More than one large vessel Extrathoracic approach Single vessel Endovascular approach First line

Trans-thoracic approach 10 year patency rates 88-94% in the largest series Operative mortality rates 3-6% Operative stroke rates 3-10%

Surgical Revascularization Innominate artery bypass/endarterectomy More Invasive Excellent patency Ernst&Stanley Current Therapy in Vascular Surgery

Innominate Endarterectomy Disease limited to the distal 2/3rd More extensive or involving the ostium, bypass should be performed. Plaque extends beyond the origin of subclavian or carotid..bypass. Bovine Arch, contraindicated

Set up Arterial lines EEG Cerebral oximetry Test Clamp Leave innominate vein Place grafts over the innominate vein

Extrathoracic approach Not endovascular candidate, single vessel disease, too much co-morbidity for transthoracic 10 year patency rates: 82-88% Operative mortality: 0.3 – 0.5% Operative stroke rates: 1-4%

Extra-thoracic Approach Subclavian transposition Minimal morbidity Excellent long-term patency Carotid subclavian bypass Minimal morbidity Excellent long-term patency

Endovascular Management Feasibility Access Cross lesions Respond to treatment Morbidity Dissection (subclavian) Neurologic events Insertion site thrombosis/hematoma Patency Technical Clinical

Technique Method of approach Prepared for both Antegrade Retrograde Percutaneous Patient comfort Operator friendly Retrograde More support for manipulations Avoidance of arch work Preferable ostial and occlusive lesions Prepared for both

Endovascular Approach No perioperative deaths or strokes 3 year patency 88% 3 year re-intervention rate 7%

Stenting Stenting preferred over PTA alone? any residual narrowing or gradient dissection Type of stent dictated by circumstance Balloon-mounted Self-expandable

Protective Measures Protective wire vertebral/subclavian DEP-distal embolic protection device Subclavian:? Innominate:?

Summary Transthoracic: Extrathoracic: Endovascular: 10 year patency rates 88-94% in the largest series Operative mortality rates 3-6% Operative stroke rates 3-10% Extrathoracic: 10 year patency rates: 82-88% Operative mortality: 0.3 – 0.5% Operative stroke rates: 1-4% Endovascular: 3 year patency rates: 88% No perioperative deaths or strokes 3 year re-intervention rate 7%

Conclusion Treatment of ostial subclavian/carotid/innominate lesions limited to symptomatic patients Patient tailored approach Endovascular first, depending upon anatomy (innominate bifurcation lesion) Role of distal protection Younger healthy patients with complex lesions Better long term patency with open